Urokinase-type plasminogen activator receptor inhibits apoptosis in triple-negative breast cancer through miR-17/20a suppression of death receptors 4 and 5

Dissection and understanding of the molecular pathways driving triple-negative breast cancer (TNBC) are urgently needed to develop efficient tailored therapies. Aside from cell invasion and metastasis, the urokinase-type plasminogen activator receptor (uPAR) has been linked to apoptosis resistance i...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xin, Wu, Bo, Chen, Lizhao, Ju, Ying, Li, Changfei, Meng, Songdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687634/
https://www.ncbi.nlm.nih.gov/pubmed/29179464
http://dx.doi.org/10.18632/oncotarget.20435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687634/
https://www.ncbi.nlm.nih.gov/pubmed/29179464
http://dx.doi.org/10.18632/oncotarget.20435

Ejemplares similares